PA
URGN icon

Parallel Advisors’s UroGen Pharma URGN Stock Holding History

Parallel Advisors’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-400
Closed -$5.48K – 3694
2025
Q2 		$5.48K Buy
+400
New +$3.84K ﹤0.01% 2711
2022
Q2 		– Sell
-3,047
Closed -$28K – 3376
2022
Q1 		$28K Buy
3,047
+3,000
+6,383% +$23.4K ﹤0.01% 1566
2021
Q4 		$0 Hold
47
– – ﹤0.01% 3303
2021
Q3 		$1K Hold
47
– – ﹤0.01% 2971
2021
Q2 		$1K Sell
47
-2,000
-98% -$36.2K ﹤0.01% 2840
2021
Q1 		$40K Buy
2,047
+944
+86% +$20K ﹤0.01% 1288
2020
Q4 		$20K Sell
1,103
-1,444
-57% -$30.3K ﹤0.01% 1482
2020
Q3 		$49K Buy
2,547
+1,500
+143% +$34K ﹤0.01% 1077
2020
Q2 		$27K Buy
+1,047
New +$25.6K ﹤0.01% 1301
2020
Q1 		– Sell
-2,700
Closed -$90K – 2661
2019
Q4 		$90K Buy
2,700
+1,200
+80% +$32.8K 0.01% 821
2019
Q3 		$36K Buy
+1,500
New +$49K ﹤0.01% 1110
2019
Q2 		– Sell
-1,000
Closed -$37K – 2439
2019
Q1 		$37K Hold
1,000
– – ﹤0.01% 968
2018
Q4 		$43K Buy
1,000
+500
+100% +$22.5K 0.01% 818
2018
Q3 		$24K Sell
500
-1,500
-75% -$69.7K ﹤0.01% 1078
2018
Q2 		$99K Buy
2,000
+1,100
+122% +$64K 0.01% 544
2018
Q1 		$45K Buy
900
+100
+13% +$5.01K 0.01% 734
2017
Q4 		$30K Hold
800
– – ﹤0.01% 873
2017
Q3 		$35K Buy
+800
New +$17.7K 0.01% 799

Other funds holding URGN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Parallel Advisors's URGN Position: Q3 2025 in Review

Parallel Advisors sold out of UroGen Pharma (URGN) in Q3 2025, closing a stake of 400 shares — an estimated $5.48K sold.

Parallel Advisors first reported a position in URGN in Q3 2017 and held it in 18 quarters. The position peaked at $99K in Q2 2018. 161 funds tracked by Wall St. Rank hold URGN as of Q3 2025.

  • Parallel Advisors reported no remaining UroGen Pharma position as of Q3 2025 after selling out during the quarter.
  • Parallel Advisors sold 400 UroGen Pharma shares in Q3 2025, an estimated $5.48K.
  • Parallel Advisors first reported a position in UroGen Pharma in Q3 2017 and held it in 18 quarters.
  • Parallel Advisors's UroGen Pharma position peaked at $99K in Q2 2018.
  • 161 funds tracked by Wall St. Rank held UroGen Pharma as of Q3 2025.

Based on Parallel Advisors's 13F filing for Q3 2025, filed 13 Nov 2025.